These insights highlight the intertwined roles of dopamine and insulin in energy balance and suggest new therapeutic avenues aimed at restoring dopamine–insulin homeostasis to prevent or reverse obesity in subjects with low D2 receptor density. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.